FDA Import Refusal AEK-4477601-9/31/1 — Crescent Pharma Ltd
The FDA refused shipment AEK-4477601-9/31/1 from Crescent Pharma Ltd (United Kingdom) on Jan 4, 2024. The refused product falls under Drugs and Biologics — SIMVASTATIN (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 4, 2024
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61JCY14 SIMVASTATIN (ANTI-CHOLESTEREMIC)
- Charges
- 75